Pharsight

Ferring Pharms Inc patents expiration

1. Clenpiq patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10624879 FERRING PHARMS INC Liquid pharmaceutical composition
Jun, 2034

(10 years from now)

US11191753 FERRING PHARMS INC Liquid pharmaceutical composition
Jun, 2034

(10 years from now)

US9827231 FERRING PHARMS INC Liquid pharmaceutical composition
Jun, 2034

(10 years from now)

Drugs and Companies using CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE ingredient

Market Authorisation Date: 28 November, 2017

Treatment: For cleansing of the colon as a preparation for colonoscopy; For cleansing the large intestine as a preparation for colonoscopy

Dosage: SOLUTION;ORAL

How can I launch a generic of CLENPIQ before it's drug patent expiration?
More Information on Dosage

CLENPIQ family patents

Family Patents

2. Milprosa patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10537584 FERRING PHARMS INC Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
Feb, 2029

(4 years from now)

US10548904 FERRING PHARMS INC Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
Feb, 2029

(4 years from now)

US8580293 FERRING PHARMS INC Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
Jan, 2030

(5 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product (NP) Apr 29, 2023

Drugs and Companies using PROGESTERONE ingredient

Market Authorisation Date: 29 April, 2020

Treatment: Method of supporting embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an assisted reproductive technology (art) treatment program for infertile women

Dosage: SYSTEM;VAGINAL

More Information on Dosage

MILPROSA family patents

Family Patents

3. Nocdurna patents expiration

NOCDURNA's oppositions filed in EPO
NOCDURNA Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10307459 FERRING PHARMS INC Pharmaceutical formulations of desmopressin
May, 2023

(9 months ago)

US9220747 FERRING PHARMS INC Methods using desmopressin acetate in orodispersible form
May, 2023

(9 months ago)

US9919025 FERRING PHARMS INC Pharmaceutical formulations of desmopressin
May, 2023

(9 months ago)

US9504647 FERRING PHARMS INC Pharmaceutical formulations of desmopressin
May, 2023

(9 months ago)

US8802624 FERRING PHARMS INC Methods of treatment using orodispersible desmopressin pharmaceutical formulations
Dec, 2023

(2 months ago)

US7947654 FERRING PHARMS INC Pharmaceutical formulations
Dec, 2023

(2 months ago)

US7560429 FERRING PHARMS INC Orodispersible dosage forms of desmopressin acetate
Feb, 2024

(28 days ago)

US11020448 FERRING PHARMS INC Methods comprising desmopressin
May, 2029

(5 years from now)

US10137167 FERRING PHARMS INC Methods comprising desmopressin
May, 2029

(5 years from now)

US9974826 FERRING PHARMS INC Methods comprising desmopressin
Apr, 2030

(6 years from now)

Drugs and Companies using DESMOPRESSIN ACETATE ingredient

Market Authorisation Date: 21 June, 2018

Treatment: Treatment of nocturia due to nocturnal polyuria in adults; Treatment of nocturia due to nocturnal polyuria in adults, comprising monitoring a patient's serum sodium concentration

Dosage: TABLET;SUBLINGUAL

More Information on Dosage

NOCDURNA family patents

Family Patents

4. Prepopik patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8481083 FERRING PHARMS INC Granular compositions of magnesium oxide and citric acid and uses thereof
Oct, 2028

(4 years from now)

US8450338 FERRING PHARMS INC Granular compositions of sodium picosulphate and potassium bicarbonate and uses thereof
Oct, 2028

(4 years from now)

Drugs and Companies using CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE ingredient

Market Authorisation Date: 16 July, 2012

Treatment: NA

Dosage: FOR SOLUTION;ORAL

How can I launch a generic of PREPOPIK before it's drug patent expiration?
More Information on Dosage

PREPOPIK family patents

Family Patents